Australian scientists have developed a novel drug which could potentially be used to effectively treat patients with diabetic retinopathy; the main
Teva Pharmaceutical Industries announced this week it is voluntarily recalling some of its blood pressure drugs in the U.S. due to an impurity in
A voluntary recall of a blood pressure medication due to impurities, which may lead to a cancer risk, was recently issued by Sandoz Inc. The company
The holidays are coming, and that means it’s travel time for many to spend time with friends and family. If you have diabetes, you should be
Eli Lilly and Company reported that it’s drug, Trulicity® significantly reduced major adverse cardiovascular events, a composite endpoint of
Out-of-control insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. According to
Xeris Pharmaceuticals, Inc. announced today that its new drug application (NDA) for its ready-to-use, room-temperature stable liquid glucagon rescue
Genentech announced yesterday that the U.S. Food and Drug Administration (FDA) has approved XOFLUZA™ for the treatment of the flu, in patients
Minnesota Attorney General Lori Swanson is the latest to file a lawsuit against the nation’s three largest insulin makers, Sanofi-Aventis U.S.
Tresiba®, an insulin degludec injection, has received an expanded approval for the treatment of Type 1 diabetes in pediatric patients in Canada.
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: